開示日時：2022/01/31 13:30:00
損益
| 決算期 | 売上高 | 営業益 | 経常益 | EPS |
| 2018.03 | 110,742,900 | 9,923,200 | 8,951,800 | 133.58 |
| 2019.03 | 114,271,300 | 9,568,700 | 8,464,200 | 141.64 |
| 2020.03 | 112,925,400 | 8,776,900 | 7,930,000 | 128.23 |
| 2021.03 | 105,656,000 | 6,730,100 | 5,536,200 | 91.92 |
※金額の単位は［万円］
株価
| 前日終値 | 50日平均 | 200日平均 | 実績PER | 予想PER |
| 1,962.0 | 1,928.84 | 1,927.23 | 34.87 | 12.43 |
※金額の単位は［円］
キャッシュフロー
| 決算期 | フリーCF | 営業CF |
| 2018.03 | 3,253,500 | 8,227,200 |
| 2019.03 | 1,902,000 | 8,521,300 |
| 2020.03 | 3,542,000 | 9,264,700 |
| 2021.03 | 1,320,400 | 7,527,100 |
※金額の単位は［万円］
▼テキスト箇所の抽出
Summary of Consolidated Financial Results for the Third Quarter of Fiscal Year 2021 Ending March 31, 2022January 31, 2022SEKISUI CHEMICAL CO., LTD.Tokyo Stock Exchange4204https://www.sekisuichemical.comCompany Name:Stock Listings:Code Number:URLRepresentative Director: Mr. Keita Kato, PresidentInquiries:TEL: Scheduled date for submission of quarterly financial statement:Scheduled date for payment of dividends:Quarterly earnings supplementary explanatory documents:Quarterly earnings results briefing: Mr. Futoshi Kamiwaki, Senior Managing Executive Officer+81-3- 6748-6467February 9, 2022-YesYes1. Consolidated Business Results for the Third Quarter (April 1, 2021 to December 31, 2021)(1) Consolidated Business Results (% figures represent changes from the same period of the previous year.)(Figures rounded down to the nearest million yen)Net Sales Operating Income Ordinary Income Net IncomeAttributable toOwners of the ParentFY2021 (First 9 months)FY2020 (First 9 months)Note. Comprehensive Income:Millions of yen57,45339,876%44.1-31.5Millions of yen62,80033,830%85.6-43.2Millions of yen12,73420,656%-38.4-48.56,478 million yen(-84.3%)FY2020 (First 9 months):41,159million yen(-20.3%)Millions of yen%10.9838,651-8.1756,422FY2021 (First 9 months):Net IncomeAttributable toOwners of the Parentper Shareyen28.5445.60Net IncomeAttributable toOwners of the Parentper Share (Diluted)yen –FY2021 (First 9 months)FY2020 (First 9 months)Note.The Companies have adopted “Accounting Standard for Revenue Recognition” (ASBJ Statement No.29, March 31, 2020) and relatedimplementation guidance from the beginning of the fiscal year ending March 31, 2022 and figures for the year ended March 31, 2022reflect this change of accounting method.(2) Consolidated Financial PositionTotal Assets Net AssetsEquity to Total Assets3rd Q of FY2021FY20201,135,2371,150,143667,849694,392Millions of yenMillions of yen%56.458.0(Reference) Equity:667,066Equity: Shareholders’ Equity including Accumulated Other Comprehensive Income3rd Q of FY2021:million yen,FY2020:640,818million yenNote.The Companies have adopted “Accounting Standard for Revenue Recognition” (ASBJ Statement No.29, March 31, 2020) and relatedimplementation guidance from the beginning of the fiscal year ending March 31, 2022 and figures for the year ended March 31, 2022reflect this change of accounting method.2. Dividend Status(Date of Record)At the endof 1st QAt the endof 2nd QDividend per ShareAt the endof 3rd QFY2020FY2021FY2021 (outlook)Note. Recent revision of dividend estimates: Noyen –yen 23.0024.003. Consolidated Outlook for FY2021 (April 1, 2021 to March 31, 2022) yen –Year-end Full yearyen yen 24.0025.0047.0049.00(% figures represent changes from the same period of the previous year.)Net Sales Operating Income Ordinary Income Net incomeAttributableto Owners of the ParentNet incomeAttributableto Owners of theParent per ShareFull YearMillions of yen1,164,100%10.2Millions of yen90,000%33.7Millions of yen94,000%50.0Millions of yen34,000%-18.2yen 76.56Note. Recent revision of consolidated earnings estimates: YesNotes(1)Significant change of subsidiary companies during the term(change of specified subsidiaries that affected the scope of consolidated reporting): No(2)Application of special methods for quarterly consolidated financial statements: YesNote: For further details please refer to “(4) Notes to Consolidated Financial Statements (Application of specialaccounting methods for the preparation of quarterly consolidated financial statements) on page 11 of the attacheddocument “II. Consolidated Financial Statement and Notes.(3)Changes to the accounting policy, changes or restatements of the accounting estimatesa) Changes caused by revisions to accounting principles: Yesb) Changes other than a): Noc) Amendments to accounting estimates: Nod) Restatements: NoNote:For further details please refer to “(4) Notes to Consolidated Financial Statements (Changes in AccountingPolicies) on page 11 of the attached document “II. Consolidated Financial Statement and Notes.”a)(4) Number of shares outstanding (common stock)Number of shares outstanding at the end ofterm (including treasury stock):Treasury stock at the end of term:b)c)Average outstanding shares in the period (quarterly consolidated cumulative total):3rd Q of FY2021FY20203rd Q of FY2021FY20203rd Q of FY20213rd Q of FY2020471,507,285476,507,28527,430,82627,573,735446,232,875452,954,646sharessharessharessharessharessharesNote: The Financial Instruments and Exchange Law does not require this brief announcement of the most recentfinancial statements to be subject to audit review.Remarks on appropriate use of forecasted results of operation and other special matters1.This report contains revisions to the consolidated forecasts for the fiscal year announced on October 28, 2021.2.The earnings forecasts and other forward-looking statements presented in this report are based on information available atthe time of its issue and on certain assumptions that the Company considers reasonable. Forward-looking statements in nocapacity represent a guarantee that the Company will achieve the stated amounts. Various factors can cause actual resultsto differ materially from the forecasts. For important matters regarding the conditions associated with the assumptions ofthese forecasts and their appropriate use, please see “2. Revision to the consolidated results forecast and other forward-looking information” on page 4 of the Quarterly Financial Report (Supplementary Material).I. Qualitative Information and Financial Review1. Consolidated Business Results(1) Group Overview (April 1, 2021 to December 31, 2021)Net Sales: 838.6 billion yen (+10.9%), Operating Income: 57.4 billion yen (+44.1%), Ordinary Income: 62.8 billion yen (+85.6%), Net Income Attributable to Owners of the Parent: 12.7 billion yen (-38.4%) In the first three quarters of fiscal 2021, besides the effects from COVID-19, there was also impact from factors such as the shortage of semiconductors and production delays due to logistics stagnation. However, sales increased due to a certain level of recovery in the domestic and overseas automobile, electronics, and construction markets, as well as in new housing constructions in Japan. Although the prices of raw materials and components rose significantly higher than expected, expanding sales volume, improving selling prices, and reducing costs led to substantial increases in operating income and ordinary income. Net income attributable to owners of the parent decreased due to the recording of an impairment loss in the second quarter of the current fiscal year at a consolidated subsidiary in the U.S. that manufactures composite molded products such as carbon fiber reinforced plastics (CFRP). Effective from the first quarter of the current fiscal year, we have adopted the “Accounting Standard for Revenue Recognition” (ASBJ Statement No. 29, March 31, 2020). Details are described in “II. Consolidated Financial Statement and Notes, (4) Notes to Consolidated Financial Statements (Changes in Accounting Policies).” (2) Overview by Business Segments (April 1, 2021 to December 31, 2021)[Housing Company] Net Sales: 373.0 billion yen (+8.3%), Operating Income: 21.3 billion yen (+28.9%) In the first three quarters of fiscal 2021, sales increased due to a recovery in orders for housing and renovation, as well as contributions such as from the smooth expansion in earnings from the Town and Community Development business. Although operating income was affected by the sharp rise in the prices of components, it increased due to the expansion of sales volume and progress in cost reduction. In terms of orders, the Housing business saw a favorable trends in subdivision and ready-built houses, resulting in a significant year-on-year increase. In the Renovation business as well, the number of opportunities to contact customers recovered, resulting in a significant increase over the same period last year. In addition, our announcement of the project commemorating the 50th anniversary of the establishment of SEKISUI HEIM and promotion of smart and resilient products throughout the entire business helped to strengthen the brand. In the Housing business, in addition to developing experience-based facilities, attracting customers via the Web, and strengthening online seminars and business negotiations, we focused on expanding sales of subdivision and ready-built houses, for which demand continues to be strong. In terms of products, we launched the New Smart Power Station FR GREENMODEL in October. It has high-capacity storage batteries that use cells made by SEKISUI CHEMICAL. We also strengthened variations such as single-story houses, and promoted products that respond to the new SEKISUI CHEMICAL (4204) Summary of Consolidated Financial Results for the Third Quarter of Fiscal Year 2021 Ending March 31, 20221 normal, such as ventilation and air conditioning systems equipped with anti-virus filters. In the Renovation business, in addition to expanding periodic checkups, we worked to expand sales of proposal-based products such as exterior wall painting and bathrooms by opening and utilizing experience-based showrooms. In the Town and Community Development business, we commenced sales for two new projects (Moriya City and Tsukuba City) in Ibaraki Prefecture. In the Real Estate business, we strengthened initiatives toward the nationwide deployment of the purchase and resale BeHeim brand. [Urban Infrastructure and Environmental Products Company] Net Sales: 149.6 billion yen (+1.8%), Operating Income: 6.2 billion yen (+10.3%) In the first three quarters of fiscal 2021, while there were effects including delays in properties overseas, sales increased due to strong demand in public works projects and capital investment within and outside Japan, as well as trend of recovery in the housing market. We secured an increase in income by working on improvement of selling prices, even though prices of raw materials rose higher than expected. In Piping and Infrastructure field, non-residential demand in Japan was sluggish and there were effects from delays in properties overseas. However, sales were strong for pipe materials for housing in Japan, pipe materials for plants due to increased capital investment in Japan and overseas, and civil engineering-related products for public works projects. This resulted in a year-on-year increase in net sales. With regard to Building and Living Environment field, net sales increased from the same period of the previous fiscal year due to strong sales in products for detached houses and condominiums, although there was impact from construction delays arising from a shortages in housing construction equipment. In Advanced Materials field, sales of synthetic lumber for railway sleepers were significantly affected by factors such as delays in overseas properties. In the area of thermo plastic sheets, although there were effects from the shortage of raw materials, transportation delays, and other factors, the development of applications for railway and construction sectors progressed in line with the economic recovery in the United States. For high-performance molded products such as clean containers, sales were strong for medical and other applications. As a result, overall net sales for the field, excluding the impact of structural reforms (business transfers), increased from the same period of the previous fiscal year. [High Performance Plastics Company] Net Sales: 263.5 billion yen (+16.9%), Operating Income: 31.5 billion yen (+53.2%) In the first three quarters of fiscal 2021, despite the growing impact of the semiconductor shortage, sales increased due to some recovery of market conditions in the automotive, electronics and other sectors. Although raw material prices continued to rise higher than expected, the Company was able to recover by expanding sales volume of high-performance products, improving selling prices, and reducing costs, resulting in a significant increase in profit. In Electronics field, sales of products for LCD panels were strong due to the recovery of the market conditions for mobile devices such as smartphones and tablets, and sales expansion in the non-LCD sector also progressed steadily, resulting in a year-on-year increase in net sales. In Mobility field, although there was further increase in the impact of the shortage of semiconductors and automobile demand in the third quarter was lower than expected, sales of high-performance SEKISUI CHEMICAL (4204) Summary of Consolidated Financial Results for the Third Quarter of Fiscal Year 2021 Ending March 31, 20222products grew, especially interlayer films for head-up displays, resulting in a significant year-on-year increase in net sales. As for SEKISUI AEROSPACE CORPORATION, we recorded an impairment loss in the second quarter of fiscal 2021 as we do not expect an early recovery in demand for aircraft due to COVID-19 affection. However, we are continuing to promote business structure reform and expansion of applications for medical equipment, etc. In Buildings and Infrastructure Materials field, there was strong demand for chlorinated polyvinyl chloride (CPVC) resin centered on India and the Middle East, and sales of fire-resistant and non-combustible materials were also strong due to recovery in the construction market, resulting in a significant year-on-year increase in net sales. [Medical Business] Net Sales: 63.7 billion yen (+23.7%), Operating Income: 8.5 billion yen (+75.7%) In the first three quarters of fiscal 2021, sales and profits increased due to the recovery of demand for diagnostics in Japan and overseas. In the Diagnostics business, there was significant growth in sales of COVID-19 test kits in the United States and reagents for blood coagulation in China, as well as strong demand in Japan for fields such as Clinical Chemistry/Immunology, resulting in a year-on-year increase in net sales. In Pharmaceuticals & Fine Chemicals business, orders in the drug development solutions recovered and net sales increased year on year.SEKISUI CHEMICAL (4204) Summary of Consolidated Financial Results for the Third Quarter of Fiscal Year 2021 Ending March 31, 20223 2. Revision to the consolidated results forecast and other forward-looking information For the full-year consolidated results forecast, although the impact of COVID-19 and shortage of semiconductors are being prolonged further than expected, a certain level of recovery is expected in some market conditions. At the same time, raw material prices are rising higher than expected and we foresee there will continue to be significant impact. However, we also expect effects such as from improved selling prices, improved product composition by expanding sales of high-performance products, and promotion of cost reduction. In addition, fixed costs are expected to decrease as a result of the revision of the simplified method of accounting for retirement benefits. Taking these factors into consideration, the forecast numbers published on October 28, 2021 have been revised as follows: Revision to Consolidated Results Forecast for the Fiscal Year Ending March 31, 2022 (April 1, 2021 to Net Income Operating Ordinary Attributable Net Income Income Income to Owners of per Share 90,000 90,000 0 0.0 the Parent 34,000 34,000 0 0.0 94,000 94,000 0 0.0 76.22 76.56 Net Sales 1,155,500 1,164,100 8,600 ＋0.7 (Reference) Results for the 1,056,560 67,300 62,649 41,544 91.92 March 31, 2022) Previous forecast (A) Revised forecast (B) Change (B – A) Change (%) previous fiscal year (Fiscal year ended March 31, 2021) Although the financial forecast is revised, no revision has been made to the dividend forecast (total annual dividend of 49 yen (interim dividend: 24 yen, year-end dividend: 25 yen)). SEKISUI CHEMICAL (4204) Summary of Consolidated Financial Results for the Third Quarter of Fiscal Year 2021 Ending March 31, 20224Ⅱ. Consolidated Financial Statement and NotesConsolidated Financial Statement (Third Quarter, Fiscal Year 2021)(1) Consolidated Balance SheetsEnd Fiscal Year 2020(As of March 31, 2021)(Millions of Yen)End Third Quarter,Fiscal 2021(As of December 31, 2021)(Assets）Current assets:Cash and depositsNotes receivable, tradeAccounts receivable, tradeMarketable securitiesMerchandise and finished goodsLand for saleWork in processRaw materials and suppliesAdvance paymentsPrepaid expensesShort-term loans receivableOther current assetsAllowance for doubtful accountsTotal current assetsFixed assets: Property, plant and equipment, net:Buildings and structuresMachinery, equipment and vehiclesLandLeased assetsConstruction in progressOtherTotal property, plant and equipment, net Intangible assets:GoodwillSoftwareLeased assetsOtherTotal intangible assets Investments and other assets:Investments in securitiesLong-term loans receivableLong-term prepaid expensesAsset for retirement benefitsDeferred tax assetsOtherAllowance for doubtful accountsTotal investments and other assets Total fixed assetsTotal assets87,45434,810135,821079,65258,76750,46934,0213,3627,121215,259-1,172505,571116,43396,84480,07919,20327,22811,607351,39750,91410,52015036,06397,649174,6561,6132,0213125,34713,908-2,334195,525644,5711,150,143116,93639,941137,894-86,31156,14260,25542,2224,0467,58419323,741-1,158574,109118,708105,73082,18418,53217,16411,568353,88710,81910,41313424,78746,155135,8121,0922,1625989,86313,766-2,214161,083561,1271,135,237SEKISUI CHEMICAL (4204) Summary of Consolidated Financial Results for the Third Quarter of Fiscal Year 2021 Ending March 31, 20225(Liabilities)Current liabilities:Notes payable, tradeElectronically recorded obligationsAccounts payable, tradeShort-term debt and current portion of long-term debtLease obligationsAccrued expensesAccrued income taxes and other taxesAllowance for bonuses to employeesAllowance for bonuses to directors and audit and supervisoryboard membersProvision for compensation for completed constructionProvision for stock-based compensationAdvances receivedOtherTotal current liabilitiesLong-term liabilities:BondsLong-term debt less current portionLease obligationsDeferred tax liabilitiesLiability for retirement benefitsProvision for stock-based compensationOtherTotal long-term liabilitiesTotal liabilities(Net assets)Shareholders’ equity:Common stockCapital surplusRetained earningsTreasury stock, at costTotal shareholders’ equityAccumulated other comprehensive income:Unrealized holding gain on securitiesDeferred loss on hedgesUnrealized gain on land revaluationTranslation adjustmentsRetirement benefit adjustmentsTotal accumulated other comprehensive incomeNon-controlling interestsTotal net assetsTotal liabilities and net assetsEnd Fiscal Year 2020(As of March 31, 2021)(Millions of Yen)End Third Quarter,Fiscal 2021(As of December 31, 2021)1,74425,05290,7987,2784,62543,91010,65817,6202451,40315740,22738,555282,27840,00071,20715,05710,36230,4026485,793173,472455,751100,002109,021441,087-43,414606,69650,781-333236,6472,65060,37027,325694,3921,150,1431,48628,96098,8053,7054,67539,84322,75610,5372451,46410457,42546,175316,18540,00058,59814,3204,17928,1597265,218151,202467,387100,002109,042423,624-44,592588,07637,300-2332212,3382,80352,74127,030667,8491,135,237SEKISUI CHEMICAL (4204) Summary of Consolidated Financial Results for the Third Quarter of Fiscal Year 2021 Ending March 31, 20226(2) Consolidated Statements of Income and Statement of Comprehensive Income(Consolidated Statements of Income)First 9 months, Fiscal Year 2021First 9 months, Fiscal 2020First 9 months, Fiscal 2021(From April 1, 2020to December 31, 2020)(From April 1, 2021to December 31, 2021)(Millions of Yen)Net salesCost of salesGross profitSelling, general and administrative expensesOperating incomeNon-operating income:Interest incomeDividends incomeEquity in earnings of affiliatesForeign exchange gain, netMiscellaneous incomeTotal non-operating incomeNon-operating expenses:Interest expensesSales discountsForeign exchange loss, netMiscellaneous expensesTotal non-operating expensesOrdinary incomeExtraordinary income:Gain on sales of investments in securitiesTotal extraordinary incomeExtraordinary loss:Loss on impairment of fixed assets and goodwillLoss on sales or disposal of property,plant and equipmentTotal extraordinary lossIncome before income taxesIncome taxesNet incomeNet income attributable to:Non-controlling interestsOwners of the parent756,422520,489235,932196,05639,8763324,1191,283-2,0467,7826162842,9449,98313,82833,830–2,0971,0543,15130,6788,93621,7421,08520,656838,651578,858259,792202,33857,4534473,7911662,0282,2368,670560–2,7643,32462,80025,88325,88350,0871,02451,11137,57223,50314,0691,33412,734SEKISUI CHEMICAL (4204) Summary of Consolidated Financial Results for the Third Quarter of Fiscal Year 2021 Ending March 31, 20227Selling, general and administrative expensesThird Quarter, Fiscal Year 2021Net salesCost of salesGross profitOperating incomeNon-operating incomeInterest incomeDividends incomeEquity in earnings of affiliatesForeign exchange gain, netMiscellaneous incomeTotal non-operating incomeNon-operating expensesInterest expensesSales discountsEquity in earnings of affiliatesForeign exchange loss, netMiscellaneous expensesTotal non-operating expensesOrdinary incomeExtraordinary incomeGain on sales of investments in securitiesTotal extraordinary incomeExtraordinary lossLoss on impairment of fixed assetsLoss on sales or disposal of property,plant and equipmentTotal extraordinary lossIncome before income taxesIncome taxesNet incomeNet income attributable to:Non-controlling interestsOwners of the parent(Millions of Yen)Third Quarter, Fiscal 2020Third Quarter, Fiscal 2021(From October 1, 2020to December 31, 2020)(From October 1, 2021to December 31, 2021)266,381182,31984,06166,58817,472102416238-814192100-1,5721,4844,1085,88613,159–1,7262011,92811,2303,2188,0113877,624290,708200,86589,84267,90921,933196399-1,0708562,523185–1,3791,0592,62421,8313,7803,7808636745425,1587,95317,20455616,648SEKISUI CHEMICAL (4204) Summary of Consolidated Financial Results for the Third Quarter of Fiscal Year 2021 Ending March 31, 20228(Consolidated Statement of Comprehensive Income)First 9 months, Fiscal Year 2021Net incomeOther comprehensive income (loss)Unrealized holding gain (loss) on securitiesDeferred (loss) gain on hedgesTranslation adjustmentsRetirement benefit adjustmentsComprehensive income (loss) of affiliatesaccounted for by the equity methodattributable to the CompanyTotal other comprehensive income (loss)Comprehensive incomeComprehensive income attributable to:Owners of the parentNon-controlling interests(Millions of Yen)First 9 months, Fiscal 2020First 9 months, Fiscal 2021(From April 1, 2020to December 31, 2020)(From April 1, 2021to December 31, 2021)21,74213,876-263,1581,2991,10819,41641,15939,4781,68014,069-12,8765,66920-7-397-7,5906,4785,1051,372SEKISUI CHEMICAL (4204) Summary of Consolidated Financial Results for the Third Quarter of Fiscal Year 2021 Ending March 31, 20229(3) Consolidated Statements of Cash FlowsOperating activities:Income before income taxesAdjustments for:Depreciation and amortizationAmortization of goodwillLoss on impairment of fixed assets and goodwillLoss on disposal of property, plant and equipmentLoss on sales of property, plant and equipmentDecrease in liability for retirement benefitsGain on sales of investments in securitiesDecrease in allowance for bonusesInterest and dividends incomeInterest expensesEquity in earnings of affiliatesDecrease (increase) in notes and accounts receivableIncrease in inventories(Decrease) increase in notes and accounts payableIncrease in advances receivedOtherSubtotalInterest and dividends receivedInterest paidIncome taxes paidNet cash provided by operating activitiesInvesting activities:Purchases of property, plant and equipment Proceeds from sales of property, plant and equipmentPayments into time depositsProceeds from withdrawal of time depositsPurchases of investments in securitiesProceeds from sales or redemption of investments in securitiesAcquisition of investments in subsidiariesPurchases of intangible assetsDecrease in short-term loans receivableOtherNet cash (used in) provided by investing activitiesFinancing activities:Increase (decrease) in short-term debt, netRepayments of lease obligationsDecrease in commercial paperProceeds from long-term debtRepayment of long-term debtRedemption of bondsCash dividends paidCash dividends paid to non-controlling interestsPurchase of treasury stockPayments from changes in ownership interests in subsidiaries that do not result in change in scope of consolidation Proceeds from issuance of common stockOtherNet cash provided by (used in) financing activitiesEffect of exchange rate change on cash and cash equivalentsNet increase in cash and cash equivalentsCash and cash equivalents at beginning of termIncrease in cash and cash equivalents from newly consolidated subsidiariesCash and cash equivalents at end of term(Millions of Yen)First 9 months, Fiscal 2020First 9 months, Fiscal 2021(From April 1, 2020to December 31, 2020)(From April 1, 2021to December 31, 2021)30,67833,3343,3162,0971,0459-2,255–8,394-4,452900-1,2839,767-17,592-16,3735,1881,90237,8904,479-831-14,52627,011-41,887608-7,7303,450-506837–4,534143,976-45,77216,728-3,892-6,00050,759-3,224-8-20,962-1,211-12,199-1,9352,63220920,8951,6303,76574,72113878,62537,57234,0602,49350,0871,01112-2,555-25,883-7,138-4,239560-166-3,619-21,4405,94217,100-6,88376,9135,070-569-15,68265,731-25,9311,371-8,15110,496-63945,763-6-5,394148717,609-2,378-4,073—13,833–21,533-1,577-9,498-39–203-53,13899531,19876,64936107,885SEKISUI CHEMICAL (4204) Summary of Consolidated Financial Results for the Third Quarter of Fiscal Year 2021 Ending March 31, 202210(4) Notes to Consolidated Financial Statements(Notes regarding the premise of a going concern)No significant changes during the term under review.(Significant Change in Shareholder Equity)No significant changes during the term under review.(Application of special accounting methods for the preparation of quarterly consolidated financial statements)Calculation of tax expenseIncome taxes are determined based on the amount of income before income taxes for the current Third Quarter ended December 31, 2021multiplied by the effective tax rate, after adoption of tax-effect accounting, estimated for the entire fiscal year ending March 31, 2022. In casewhere the estimated effective tax rate is notably lacking rationality, statutory tax rate is used.Deferred income taxes are included in income taxes.(Changes in Accounting Policies)Adoption of the Accounting Standard for Revenue RecognitionThe Companies have adopted “Accounting Standard for Revenue Recognition” (ASBJ Statement No.29, March 31, 2020) and relatedimplementation guidance from the beginning of the fiscal year ending March 31, 2022, and recognize revenue at the amount expected to bereceived in exchange for its goods or services when the dominance of the promised goods or services is transferred to a customers.As a result of its change, Rebate which was conventionally recorded as Selling, general and administrative expenses and Sales discounts whichwas conventionally recorded as Non-operating expenses, has been deducted from Net sales.And if a contract includes a variable amount, the Companies include it in the transaction price only when a significant reversal in the amount ofcumulative revenue recognized will not occur once the uncertainty related to the variable consideration is subsequently resolved.For Charged supplying, annihilation of inventories was conventionally recognized when it is paid to the suppliers, but the Companies haschanged its accounting method to not to recognize the annihilation, as it was substantially bearing the obligation to buy the supplied products.With regard to the adoption of the Revenue Recognition Standards, in accordance with the transitional treatment stipulated in the proviso toparagraph 84 of the Accounting Standard for Revenue Recognition, the cumulative effect of retroactively adopting the new accounting policyprior to the beginning of the fiscal year ending March 31, 2022, has been added to or deducted from retained earnings at the beginning of thefiscal year ending March 31, 2022 and the new accounting policy has been adopted from the beginning balance of the fiscal year ending March31, 2022.As a result, for First 9 months of the fiscal year ending March 31, 2022, Net Sales decreased by ¥2,727 million, Cost of Sales decreased by¥503 million, Selling, general and administrative expenses decreased by ¥1,835 million, and Non-operating expenses decreased by ¥311million. Therefore, Operating income decreased by ¥387 million, Ordinary income and Income before income taxes decreased by ¥76 millionrespectively.Furthermore, retained earnings at the beginning of the fiscal year ending March 31, 2022 has been decreased by ¥587 million.Adoption of the Accounting Standard for Fair Value MeasurementThe Companies have adopted “Accounting Standard for Fair Value Measurement” (ASBJ Statement No.30, July 4, 2019) and relatedimplementation guidance from the beginning of the fiscal year ending March 31, 2022. Based on the transitional treatment prescribed inParagraph 19 of the Accounting Standard for Fair Value Measurement and Paragraph 44-2 of the “Accounting Standard for FinancialInstruments” (ASBJ Statement No.10, July 4, 2019), the Companies have decided to apply the new accounting policies set forth by theAccounting Standard for Fair Value Measurement into the future. These changes had no impact on the quarterly consolidated financialstatements.SEKISUI CHEMICAL (4204) Summary of Consolidated Financial Results for the Third Quarter of Fiscal Year 2021 Ending March 31, 202211(Segment Information)Consolidated First 9 months, Fiscal 2021 (April 1, 2021 to December 31, 2021)1. Information as to sales and income (loss) on each reportable segment and its details Reportable SegmentsHousing（Note1）UrbanInfrastructure&EnvironmentalProductsHighPerformancePlastics(Millions of Yen)MedicalTotalOther（Note1・2）Total372,121—873-372,995102373,09821,394117,0419,9463,9503,8644,2081,194140,2049,404149,6096,26082,13546,41644,05043,49636,8275,861258,7874,806263,59431,53426,85521,0565,0278,2281,99759963,765063,7668,517598,15577,41953,02755,58943,9067,654835,75314,314850,06867,7052,49513-31572-2,897922,989-7,605600,65077,43253,02755,90543,9797,654838,65114,407853,05860,100Net Sales: Japan North America Europe China Asia Others Sales to third parties Intersegment sales or transfersNet salesSegment income (loss)Notes1.Net Sales of Housing segment in Japan includes ¥29,936 million that does not correspond to revenue generated from contracts withcustomers.Net Sales of other segment in Japan includes ¥628 million that does not correspond to revenue generated from contracts withcustomers.Other represents segments other than the reportable segments, which includes provision of services and manufacturing and sales of film-type lithium-ion batteries and products not included in the company’s reportable segments.2.2.Information on the difference between the total amount of the reportable segments in the above tables and the corresponding amount reported in the consolidated financial statements (Items related to the difference)Income(Millions of Yen)Total of reportable segmentsOther lossEliminationsCorporate expenses (Note)Total operating income reported in theconsolidated statements of income67,705-7,605291-2,93857,453Note: Corporate expenses are mainly general administrative expenses not attributable to each reportable segment.3. Notes relating to changes in reportable segmentsAs described in (Changes in Accounting Policies), the Companies have adopted the accounting standard and related implementationguidance from the beginning of the fiscal year ending March 31, 2022, and changed the accounting method for revenue recognition.The method for measuring profit or loss in the reportable segment was also changed.As a result, amounts for First 9 months of the fiscal year ending March 31, 2022 has been decreased by below:(Housing) Net sales decreased by ¥727 million and Segment income decreased by ¥46 million.(Urban Infrastructure & Environmental Products) Net sales decreased by ¥899 million and Segment income decreased by ¥115 million.(High Performance Plastics) Net sales decreased by ¥1,005 million and Segment income decreased by ¥131 million.(Medical) Net sales decreased by ¥93 million and Segment income decreased by ¥93 million.4. Information on impairment loss on Fixed assets or Goodwill, etc., for each reporting segments(The impairment loss on Fixed assets)As a result of reviewing the timing of market recovery in the aircraft industry in light of the prolonged impact of the COVID-19 pandemicon a consolidated subsidiary (SEKISUI AEROSPACE CORPORATION Group), which belongs to High Performance Plastics Segmentand develops, manufactures, and sells carbon fiber reinforced plastic (CFRP) and other composite molded products for aircraft in theUnited States, the Companies recorded impairment loss.The amount of impairment loss recorded in the First 9 months of the fiscal year ending March 31, 2022 was ¥49,548 million.(Important change in the amount of Goodwill)SEKISUI AEROSPACE CORPORATION Group, which belongs to High Performance Plastics Segment, recorded impairment loss onGoodwill and decreased the amount of Goodwill.The amount of impairment loss recorded in the First 9 months of the fiscal year ending March 31, 2022 was ¥37,419 million.SEKISUI CHEMICAL (4204) Summary of Consolidated Financial Results for the Third Quarter of Fiscal Year 2021 Ending March 31, 202212Consolidated Third Quarter, Fiscal 2021 (October 1, 2021 to December 31, 2021)1. Information as to sales and income (loss) on each reportable segment and its details Reportable SegmentsHousing（Note1）UrbanInfrastructure&EnvironmentalProductsHighPerformancePlastics(Millions of Yen)MedicalTotalOther（Note1・2）Total123,023—248-123,27252123,3246,56542,4583,4871,2451,6951,39131650,5952,92653,5213,05029,06116,08814,92516,61312,8862,13391,7091,77093,48012,2199,4729,2111,3822,97585520524,103024,1033,629204,01528,78717,55221,28415,3832,656289,6804,749294,43025,4648865-1278-1,027391,067-2,419204,90228,79317,55221,41215,3912,656290,7084,789295,49723,045Net Sales: Japan North America Europe China Asia Others Sales to third parties Intersegment sales or transfersNet salesSegment income (loss)Notes1.2.Net Sales of Housing segment in Japan includes ¥10,438 million that does not correspond to revenue generated from contracts withNet Sales of other segment in Japan includes ¥204 million that does not correspond to revenue generated from contracts withOther represents segments other than the reportable segments, which includes provision of services and manufacturing and sales of film-type lithium-ion batteries and products not included in the company’s reportable segments.2.Information on the difference between the total amount of the reportable segments in the above tables and the corresponding amount reported in the consolidated financial statements (Items related to the difference)Income(Millions of Yen)Total of reportable segmentsOther lossEliminationsCorporate expenses (Note)Total operating income reported in theconsolidated statements of income25,464-2,419166-1,27821,933Note: Corporate expenses are mainly general administrative expenses not attributable to each reportable segment.3. Notes relating to changes in reportable segmentsAs described in (Changes in Accounting Policies), the Companies have adopted the accounting standard and related implementationguidance from the beginning of the fiscal year ending March 31, 2022, and changed the accounting method for revenue recognition.The method for measuring profit or loss in the reportable segment was also changed.As a result, amounts for the Third Quarter of the fiscal year ending March 31, 2022 has been decreased by below:(Housing) Net sales decreased by ¥183 million and Segment income decreased by ¥28 million.(Urban Infrastructure & Environmental Products) Net sales decreased by ¥220 million and Segment income decreased by ¥44 million.(High Performance Plastics) Net sales decreased by ¥316 million and Segment income decreased by ¥43 million.(Medical) Net sales decreased by ¥68 million and Segment income decreased by ¥68 million.SEKISUI CHEMICAL (4204) Summary of Consolidated Financial Results for the Third Quarter of Fiscal Year 2021 Ending March 31, 202213
